Correlation Engine 2.0
Clear Search sequence regions


  • humans (1)
  • mental status (1)
  • midazolam (5)
  • patient (1)
  • persist (1)
  • Sizes of these terms reflect their relevance to your search.

    Ketamine continues to demonstrate its utility and safety in the austere and prehospital environment, but myths persist regarding the frequency of behavioral disturbances and unpleasant reactions. These myths have led to protocolled midazolam co-administration. Properties of midazolam and other benzodiazepines have the potential to cause significant morbidity and potential mortality. Because of this risk, benzodiazepines should only be administered when the treating provider determines that the patient's symptoms warrant it. We also present evidence that agitation and altered mental status (AMS) encountered with ketamine occurs during titration of lower pain control regimens and is much less likely to occur with higher doses. As such, in most prehospital situations, the treatment for this "incomplete dissociation" is more ketamine, not the addition of a potentially dangerous benzodiazepine. 2022.

    Citation

    Hugh M Hiller, Brendon Drew, Andrew D Fisher, Matthew Cuthrell, James C Spradling. The Myths of Uncontrolled Emergence Reactions and Consideration to Stop Mandatory, Protocolled Midazolam Coadministration With Ketamine. Journal of special operations medicine : a peer reviewed journal for SOF medical professionals. 2022;22(1):49-54

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35278314

    View Full Text